[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334552-105":59,"doc-detail-334552-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prmt1-mediated-pgk1-arginine-methylation-promotes-colorectal-cancer-glycolysis-and-tumorigenesis","PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis","","Colorectal cancer cells can display the Warburg effect by enhancing glycolysis while suppressing mitochondrial TCA cycle activity, yet the molecular basis of glycolysis pathway dysregulation remains unclear. This study identifies protein arginine methyltransferase 1 (PRMT1) as a driver of glycolysis, proliferation, and tumorigenesis in CRC. PRMT1 asymmetrically dimethylates PGK1 at R206 (meR206-PGK1), increasing S203 phosphorylation (pS203-PGK1) and suppressing mitochondrial function to promote glycolysis. Patient tissue analyses show PRMT1 and meR206-PGK1 correlate with pS203-PGK1, and higher meR206-PGK1 associates with poor survival, supporting their value as prognostic biomarkers and highlighting arginine methyltransferase inhibitors as potential CRC therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prmt1-mediated-pgk1-arginine-methylation-promotes-colorectal-cancer-glycolysis-and-tumorigenesis/334552/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prmt1-mediated-pgk1-arginine-methylation-promotes-colorectal-cancer-glycolysis-and-tumorigenesis/334552.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does PRMT1 play in colorectal cancer cells?","Question",{"text":112,"@type":113},"PRMT1 promotes glycolysis, proliferation, and tumorigenesis in colorectal cancer (CRC) cells, driving disease progression through a defined molecular pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PRMT1 modify PGK1, and what is the downstream effect?",{"text":117,"@type":113},"PRMT1 asymmetrically dimethylates PGK1 at R206 (meR206-PGK1), which enhances phosphorylation at S203 (pS203-PGK1). This inhibits mitochondrial function and supports glycolytic activity and tumor progression.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are meR206-PGK1 and PRMT1 considered potential biomarkers?",{"text":121,"@type":113},"PRMT1 and meR206-PGK1 expression positively correlate with pS203-PGK1 in patient tissues, and meR206-PGK1 is associated with poor patient survival, indicating prognostic value.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334552,1790195113,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nPRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis  \nHao Liu1,2,9, Xintian Chen3,9, Pengfei Wang4, Miaolei Chen2, Chuyin Deng2, Xingyou Qian2, Jin Bai 2,5,6 ✉, Zhongwei Li 2,7 ✉ and Xiangyang Yu1,8 ✉  \n© The Author(s) 2024  \n\n|  | Many types of cancer cells, including colorectal cancer cells (CRC), can simultaneously enhance glycolysis and repress the mitochondrial tricarboxylic acid (TCA) cycle, which is called the Warburg effect. However, the detailed mechanisms of abnormal activation of the glycolysis pathway in colorectal cancer are largely unknown. In this study, we reveal that the protein arginine methyltransferase 1 (PRMT1) promotes glycolysis, proliferation, and tumorigenesis in CRC cells. Mechanistically, PRMT1-mediatedarginine asymmetric dimethylation modiﬁcation of phosphoglycerate kinase 1 (PGK1, the ﬁrst ATP-producing enzyme in glycolysis) at R206 (meR206-PGK1) enhances the phosphorylation level of PGK1 at S203 (pS203-PGK1), which inhibits mitochondrial function and promotes glycolysis. We found that PRMT1 and meR206-PGK1 expression were positively correlated with pS203-PGK1 expression in tissues from colorectal cancer patients. Furthermore, we also conﬁrmed that meR206-PGK1 expression is positively correlated with the poor survival of patients with colorectal cancer. Our ﬁndings show that PRMT1 and meR206-PGK1 may become promising predictive biomarkers for the prognosis of patients with CRC and that arginine methyltransferase inhibitors have great |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| potential in colorectal cancer treatment. |  |  |\n|  | Cell Death and Disease (2024)15:170; [https://doi.org/10.1038/s41419-024-06544-6](https://doi.org/10.1038/s41419-024-06544-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe incidence and mortality of colorectal cancer (CRC) continue to increase [1] . Early diagnosis and treatment are effective methods to reduce colorectal cancer mortality [2], and fully analyzing the molecular mechanism of CRC occurrence and development has great signiﬁcance for early diagnosis and treatment.  \nEnhanced glycolysis signiﬁcantly promotes tumor progression [3] . Targeting glycolysis is very attractive for tumor therapy. Currently, a variety of drugs targeting glucose transporters, hexokinases, and lactate dehydrogenase in the process of glycolysis have entered clinical trials [4] . Several articles have reported abnormal glycolysis enhancement in CRC [5, 6], but the detailed mechanism of abnormal glycolysis has not yet been clariﬁed, and the targeted glycolysis process is a potential scheme for the treatment of CRC.  \nProtein methyltransferases play a key role in the progression of tumors, and arginine methyltransferases (PRMTs) and lysine methyltransferases mainly catalyze protein methylation [7, 8] . Arginine methyltransferase inhibitors have been reported to signiﬁcantly inhibit pancreatic cancer deterioration, and the US FDA approved tazemetostat, the ﬁrst inhibitor of the lysine methyltransferase EZH2, for the treatment of epithelioid sarcoma and follicular lymphoma [9, 10] . PRMT1 is the most  \nactive arginine methyltransferase in the PRMT family, as well asthe most dominant type I PRMT in mammalian cells [11] . In recent years, the role of PRMT1 in the metabolism of hepatocellular carcinoma has been widely discussed. PRMT1-mediated phosphoglycerate dehydrogenase methylation can promote serine accumulation in hepatocellular carcinoma [12], and can enhance glycolysis in hepatocellular carcinoma cells and promote the progression of liver cancer by methylating thymidine kinase and remodeling the actin cytoskeleton [13, 14] . We previously reported that PRMT1 catalyzes EZH2 methylation modiﬁcation and promotes the progression of breast cancer [15–17] . Abnormal glycolysis activation is often found in CR","cbCaiep9D9zc2AWe","https://ap.wps.com/l/cbCaiep9D9zc2AWe","pdf",5117015,12,"English","# Introduction\n## Background on colorectal cancer progression and glycolysis\n## Targeting glycolysis and the role of protein methyltransferases\n# Key findings\n## PRMT1 promotes glycolysis, proliferation, and tumorigenesis in CRC\n## PRMT1-mediated meR206-PGK1 and S203 phosphorylation link to mitochondrial suppression\n## Clinical correlations with patient outcomes","[{\"question\":\"What role does PRMT1 play in colorectal cancer cells?\",\"answer\":\"PRMT1 promotes glycolysis, proliferation, and tumorigenesis in colorectal cancer (CRC) cells, driving disease progression through a defined molecular pathway.\"},{\"question\":\"How does PRMT1 modify PGK1, and what is the downstream effect?\",\"answer\":\"PRMT1 asymmetrically dimethylates PGK1 at R206 (meR206-PGK1), which enhances phosphorylation at S203 (pS203-PGK1). This inhibits mitochondrial function and supports glycolytic activity and tumor progression.\"},{\"question\":\"Why are meR206-PGK1 and PRMT1 considered potential biomarkers?\",\"answer\":\"PRMT1 and meR206-PGK1 expression positively correlate with pS203-PGK1 in patient tissues, and meR206-PGK1 is associated with poor patient survival, indicating prognostic value.\"}]","PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis | PDF",1790007184]